NP47827 Multiple Sclerosis Medicines
- Hankija
- The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Avaldatud
- 2026-10-26
- Tähtaeg
- Pole esitatud
- Allikad
- UK_FTS
- Väärtus
- 30403887.0 GBP
Kirjeldus
Kirjeldus on allika keeles.
The Authority seeks to establish a Framework Agreement covering Multiple Sclerosis medicines. The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): Glatiramer acetate Interferon beta-1a Teriflunomide Dimethyl fumarate Fingolimod Natalizumab Cladribine
CPV: 33600000
Liikmesus
Teadete eelvaated on tasuta. Ametlike teadete ja dokumentide lingid, ehitusload ning isiklik MCP juurdepääs nõuavad aktiivset tasulist liikmesust.
Loe